|
|
Nutri Pharma ASA - Earning & Dividend Analysis Snapshot
This detailed Report provides an Earnings and Dividends history for Nutri Pharma ASA. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.
Nutri Pharma ASA. The Group's principal activity is to develop products that beneficially influence lifestyle related disorders. The lifestyle related diseases are obesity, hyperlipidaemia and type 2 diabetes. The Group develops a range of products based on soy ingredients, using isolated soy protein with high levels of isoflavones and cotyledon soy fibre. The soy technology prevents the development of life style related diseases such as obesity, elevated cholesterol levels and type 2 diabetes. The Group operates in two segments: Royalty and Direct Sales. Products include Nutrilett (weight management), Abacor (cholesterol reduction) and Abalon (for diabetes treatment).
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
|
|
|
|